Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Title
Intervention Indication Therapeutic Area Year Actions
Pembrolizumab (Keytruda) for relapsed/refractory classical Hodgkin lymphoma Pembrolizumab (Keytruda; MK-3475) Hodgkin lymphoma Haematological Cancer and Lymphomas 2018 View  |  Download
Pembrolizumab (Keytruda) for triple negative breast cancer Pembrolizumab (Keytruda; MK-3475) Breast cancer Breast Cancer 2017 View  |  Download
Pembrolizumab (KEYTRUDA) in combination with carboplatin-paclitaxel/Nab-paclitaxel for metastatic squamous non small cell lung cancer, first line Carboplatin (Paraplatin) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) , Paclitaxel (Taxol; paclitaxel albumin) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2017 View  |  Download
Pembrolizumab addition to chemotherapy, followed by maintenance with olaparib for BRCA non-mutated advanced epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer – First-line Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) , Pembrolizumab (Keytruda; MK-3475) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2020 View  |  Download
Pembrolizumab adjuvant for urothelial carcinoma and/or localised muscle invasive bladder cancer Pembrolizumab (Keytruda; MK-3475) Urothelial cancer Urological Cancer 2024 View  |  Download
Pembrolizumab and chemoradiation for treating muscle-invasive, non-metastatic bladder cancer Chemoradiotherapy , Pembrolizumab (Keytruda; MK-3475) Bladder cancer Urological Cancer 2023 View  |  Download
Pembrolizumab and chemotherapy for resectable nonsmall-cell lung cancer Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Pembrolizumab and chemotherapy with or without radiotherapy as an adjuvant therapy for treating newly diagnosed high-risk endometrial cancer Chemotherapy , Pembrolizumab (Keytruda; MK-3475) Endometrial cancer Female Reproductive Cancer 2022 View  |  Download
Pembrolizumab as adjuvant therapy for resected high-risk stage II melanoma Pembrolizumab (Keytruda; MK-3475) Melanoma Skin Cancer 2020 View  |  Download
Pembrolizumab for Advanced Hepatocellular Carcinoma – second line onwards Pembrolizumab (Keytruda; MK-3475) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2018 View  |  Download
1 2 73 74 75 76 77 113 114
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications